A phase Ia/Ib, dose-escalation/expansion study of BI 907828 in combination with BI 754091 (ezabenlimab) and BI 754111 in patients (pts) with advanced solid tumors Meeting Abstract
| Authors: | Yamamoto, N.; Hafez, N.; Tolcher, A. W.; Teufel, M.; Geng, J.; Svensson, L.; Lahmar, M.; Gounder, M. M. |
| Abstract Title: | A phase Ia/Ib, dose-escalation/expansion study of BI 907828 in combination with BI 754091 (ezabenlimab) and BI 754111 in patients (pts) with advanced solid tumors |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300988 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.3095 |
| Notes: | Meeting Abstract: 3095 -- Meeting also held virtually -- Source: Wos |
